<DOC>
	<DOC>NCT01791127</DOC>
	<brief_summary>The objective of the SIELLO study is to demonstrate the safety and effectiveness of the BIOTRONIK Siello S pacing lead.</brief_summary>
	<brief_title>Safety and Performance Study of the Siello S Pacing Lead</brief_title>
	<detailed_description />
	<criteria>Candidate for de novo implantation of a BIOTRONIK pacemaker system, including one or two Siello S leads. Candidate meets recommendation for pacemaker system implant put forth by guidelines of relevant professional societies. Able to understand the nature of the study and provide informed consent. Available for followup visits on a regular basis at the investigational site for the expected 5 years of followup. Age greater than or equal to 18 years. Enrolled in any other investigational clinical study. Currently implanted with a pacemaker or ICD device. Planned cardiac surgical procedures or interventional measures within the next 6 months. Expected to receive a heart transplant within 1 year. Life expectancy less than 1 year. Presence of another lifethreatening, underlying illness separate from their cardiac disorder. Pregnant at the time of enrollment.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>